https://www.marketscreener.com/quote/stock/IMUGENE-LIMITED-10353137/news/Imugene-doses-first-patient-in-intravenous-monotherapy-arm-of-Phase-1-clinical-trial-45964722/?utm_source=telegram&utm_medium=social&utm_campaign=share